Inyx to Present at Rodman & Renshaw Healthcare Conference
May 02 2005 - 10:01AM
PR Newswire (US)
Inyx to Present at Rodman & Renshaw Healthcare Conference NEW
YORK, May 2 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI)
(BULLETIN BOARD: IYXI) , a specialty pharmaceutical company with a
focus on niche drug delivery technologies and products, will be
presenting at the Rodman & Renshaw Techvest Annual Global
Healthcare Conference in Paris, France. Inyx's presentation will be
this Thursday, May 5, at 4:35 p.m. Paris time, which is 10:35 a.m.
Eastern Daylight Time in the United States. A webcast of the Inyx
presentation will be available both live and on a recorded basis
for 90 days afterwards at:
http://www.wsw.com/webcast/rrshq5/iyxi.ob. The webcast link can
also be accessed from the Investor Relations/Investor Presentation
section at Inyx's website: http://www.inyxinc.com/. The
presentation will feature an overview of Inyx's business niches and
corporate goals, including Inyx's just completed acquisition of the
assets and certain business of Aventis Pharmaceuticals Puerto Rico
from Aventis Pharmaceuticals, Inc., a wholly owned subsidiary of
sanofi-aventis Group (NYSE:SNY). Inyx will also discuss other new
business and strategic relationships the Company is gaining as well
as Inyx's own initial proprietary products that are expected to be
ready for commercial marketing by the end of 2005. About Inyx Inyx,
Inc. is a specialty pharmaceutical company with aerosol drug
delivery technologies and products for the treatment of
respiratory, allergy, dermatological, topical and cardiovascular
conditions. Inyx focuses its expertise on both prescription and
over-the-counter pharmaceutical products, and provides specialty
pharmaceutical development and production consulting services to
the international healthcare market. In addition, Inyx is
developing its own proprietary products to be marketed by selected
clients and strategic partners, which include some of the largest
pharmaceutical companies. The company's operations are conducted
through several wholly owned subsidiaries: Inyx USA, Ltd., which
has newly acquired operations in Manati, Puerto Rico; Inyx Pharma
Limited, which has development and production facilities located
near Manchester, England; and Inyx Canada, Inc. based in Toronto,
which provides business development and support services. Inyx,
Inc.'s corporate offices are in New York City. For more
information, please visit: http://www.inyxinc.com/. Safe Harbor
Statements about the Company's future expectations, including
future revenues and earnings, and all other statements in this
press release other than historical facts, are "forward-looking
statements" within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934, and as
that term is defined in the Private Securities Litigation Reform
Act of 1995. The Company intends that such forward-looking
statements be subject to the safe harbors created thereby. Since
these statements involve risks and uncertainties and are subject to
change at any time, the Company's actual results could differ
materially from expected results. For more information, please
contact: Jay M. Green, Executive VP Inyx, Inc. DATASOURCE: Inyx,
Inc. CONTACT: Jay M. Green, Executive VP of Inyx, Inc., Web site:
http://www.inyxinc.com/
Copyright